Oct 27, 2026 7:00am EDT Tonix Pharmaceuticals Presented an Analysis of Phase 3 Data Demonstrating TONMYA® Improved Physical Symptoms and Functional Ability of Patients with Fibromyalgia at the IASP 2026 World Congress on Pain
Oct 26, 2026 7:00am EDT Tonix Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 9, 2026
